Pressure Biosciences Inc (PBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14 | 3 | 81 | 5 | 25 |
| Receivables | 184 | 145 | 151 | 329 | 189 |
| Inventories | 542 | 597 | 305 | 467 | 554 |
| Other current assets | 0 | 1 | 0 | 0 | 0 |
| TOTAL | $874 | $957 | $760 | $1,021 | $1,049 |
| Non-Current Assets | |||||
| PPE Net | 72 | 79 | 85 | 91 | 93 |
| Investments And Advances | 64 | 66 | 62 | 78 | 84 |
| Intangibles | 5,287 | 5,324 | 0 | 252 | 274 |
| Other Non-Current Assets | 582 | 565 | 143 | 160 | 176 |
| TOTAL | $6,006 | $6,034 | $290 | $581 | $627 |
| Total Assets | $6,879 | $6,992 | $1,050 | $1,602 | $1,676 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 28,467 | 26,352 | 22,597 | 20,901 | 22,413 |
| Accounts payable and accrued liabilities | 2,494 | 4,649 | 1,320 | 1,063 | 912 |
| Accrued Expenses | 4,064 | 3,717 | 3,052 | 3,099 | 2,849 |
| Other current liabilities | 8,114 | 9,412 | 6,306 | 4,576 | N/A |
| TOTAL | $43,575 | $44,569 | $33,576 | $29,958 | $26,541 |
| Non-Current Liabilities | |||||
| Long Term Debt | 161 | 161 | 162 | 163 | 163 |
| Deferred Revenues | 230 | 234 | 234 | 253 | 302 |
| Other Non-Current Liabilities | 359 | 380 | 61 | 71 | 81 |
| TOTAL | $532 | $549 | $227 | $245 | $250 |
| Total Liabilities | $44,107 | $45,118 | $33,804 | $30,203 | $26,791 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,967 | 37,379 | 34,711 | 21,726 | 17,762 |
| Common Shares | 541 | 471 | 354 | 234 | 196 |
| Retained earnings | -186,193 | -177,735 | -169,029 | -158,493 | -152,231 |
| Other shareholders' equity | 35,894 | 35,684 | 35,684 | 35,684 | 35,684 |
| TOTAL | $-37,228 | $-38,127 | $-32,754 | $-28,601 | $-25,115 |
| Total Liabilities And Equity | $6,879 | $6,992 | $1,050 | $1,602 | $1,676 |